DexCom

Yahoo Finance • 7 days ago

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders

SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches... Full story

Yahoo Finance • 19 days ago

2 Growth Stocks to Buy in the Tariff-Fueled Market Correction

What should investors do during a market downturn? Some might resort to panic selling, but that's hardly a good strategy. Unless a company's investment thesis has changed because of recent developments, market downturns aren't a good enoug... Full story

Yahoo Finance • 28 days ago

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in... Full story

Yahoo Finance • last month

Dexcom Appoints Jon Coleman as Chief Commercial Officer

SAN DIEGO, March 25, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibil... Full story

Yahoo Finance • 2 months ago

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career Mr. Durso led biopharmaceuti... Full story

Yahoo Finance • 3 months ago

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Medical device specialist DexCom(NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to unimpressive financial results, especially i... Full story

Yahoo Finance • 7 months ago

Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks

Five weeks ago, what can arguably be described as the most important data release of the third-quarter occurred -- and I'm not talking about the July inflation report. No later than 45 calendar days following the end to a quarter (Aug. 14... Full story

Yahoo Finance • 8 months ago

Is DexCom a Millionaire-Maker Stock?

Medical device specialist DexCom(NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps put things in perspective. The healthcare comp... Full story

Yahoo Finance • 8 months ago

2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200

The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more accessible -- and perfectly sensible -- strategy is to invest relatively small sums regularly. Even $200 c... Full story

Yahoo Finance • 8 months ago

RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents

Québec residents ages two and older living with type 1 diabetes may now be eligible to receive coverage for Dexcom G7. (Photo: Business Wire) Québec becomes the latest province to offer public coverage for Dexcom G7, helping those living... Full story

Yahoo Finance • 9 months ago

The 'G' in ESG is gaining more shareholder love than the 'E' or 'S'

Shareholders asked to approve new ESG policies are warming up to the "G" even as they continue withholding support for the "E" and "S." "G" refers to corporate “governance" changes, and such proposals received considerably more shareholde... Full story

Yahoo Finance • 9 months ago

Quanta Services Inc. (PWR): Among the Top Stocks Recommended by Navellier & Associates?

We recently compiled a list of the 10 Best Stocks to Buy According to Navellier & Associates.In this article, we are going to take a look at where Quanta Services Inc. (NYSE:PWR) stands against the other stocks approved by Navellier & Asso... Full story

Yahoo Finance • 9 months ago

Is Beaten-Down Dexcom Stock a Buy on the Dip?

Last week was a tough one for Dexcom(NASDAQ: DXCM) shareholders. The maker of continuous blood glucose monitors lowered its forward revenue outlook when it reported second-quarter results on Friday, July 26. If there's one thing markets h... Full story

Yahoo Finance • 9 months ago

2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000

Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested through market highs and lows, and consistent... Full story

Yahoo Finance • 9 months ago

Insiders At DexCom Sold US$18m In Stock, Alluding To Potential Weakness

Over the past year, many DexCom, Inc. (NASDAQ:DXCM) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually more valuable to know whether insiders are b... Full story

Yahoo Finance • 10 months ago

Possible Bearish Signals With DexCom Insiders Disposing Stock

Over the past year, many DexCom, Inc. (NASDAQ:DXCM) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually more valuable to know whether insiders are b... Full story

Yahoo Finance • 11 months ago

Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes

EDINBURGH, Scotland, June 04, 2024--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for... Full story

Yahoo Finance • 11 months ago

Google Parent Alphabet Is Selling Shares of 2 Hypergrowth Stocks and Piling Into a Promising Artificial Intelligence (AI) Company

Once every quarter, institutional money managers with more than $100 million in assets under management are required to file Form 13F with the Securities and Exchange Commission. A 13F provides an under-the-hood look at what Wall Street's... Full story

Yahoo Finance • last year

14 Best Medical Device Stocks To Buy Now

In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now. You can skip our detailed analysis of the Medical Device Industry and go directly to the 5 Best Medical Device Stocks To Buy Now. The healthcare sector relies... Full story

Yahoo Finance • last year

Dexcom Announces Upcoming Conference Presentation

SAN DIEGO, February 27, 2024--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual Raymond James Institu... Full story